Welcome to Molplex Pharmaceuticals
Molplex is a new class of pharmaceutical company, using its innovative technology to identify and optimise novel treatments for infection, cancer and other serious diseases.
Its pipeline of small-molecule therapeutics is driven by our proprietary platform for drug optimisation, Optiplex - a highly scalable system combining automated decision-making with laboratory automation. Optiplex delivers safer and more effective drugs at radically lower cost.
Molplex aims to discover novel treatments quicker and more effectively, improving the health of patients around the globe.